Literature DB >> 12631127

Endothelial dysfunction and inflammation in asymptomatic proteinuria.

Karen E Paisley1, Martin Beaman, John E Tooke, Vidya Mohamed-Ali, Gordon D O Lowe, Angela C Shore.   

Abstract

BACKGROUND: Proteinuria is associated with vascular risk and a systemic increase in vascular permeability. Endothelial dysfunction occurs early in atherosclerosis and modulates vascular permeability. Vascular risk and chronic inflammation are associated. This study investigates whether the increased vascular permeability in proteinuria reflects systemic endothelial dysfunction and chronic inflammation.
METHODS: Twenty-one patients with asymptomatic proteinuria (1.29 g/24 h; range 0.18 to 3.17) and 21 matched controls were studied. Microvascular endothelial function was assessed using acetylcholine iontophoresis. Maximum microvascular hyperemia (MMH) was assessed by flux response to local skin heating. Macrovascular endothelial function was assessed by flow-associated dilation (FAD) in the brachial artery using ultrasound. von Willebrand factor (vWF) was measured as a marker of endothelial activation. Low-grade inflammation was assessed by measurement of circulating C-reactive protein (CRP) values using a high sensitivity assay.
RESULTS: FAD was impaired in proteinuric subjects (AP) compared to controls [1.8 (0.2 to 5.3) AP vs. 3.8 (1.5 to 6.2) C %; P = 0.014]. There was no significant difference between groups in MMH or in the response to acetylcholine iontophoresis. The AP group had a higher CRP [4.0 (0.5 to 39.0) AP vs. 0.2 (0.1 to 21.3) C mg/L; P < 0.001] and tendency to higher vWF [101.5 (67.0 to 197.0) AP vs. 77.5 (45.0 to 185.0) C IU/dL; P = 0.046] compared to controls. In the AP, but not control, group there was an inverse correlation between CRP and microvascular function as determined by acetylcholine iontophoresis (r = -0.509; P = 0.018).
CONCLUSIONS: In AP subjects there is evidence of macrovascular endothelial dysfunction remote from the kidney and of low-grade inflammation that is associated with microvascular endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631127     DOI: 10.1046/j.1523-1755.2003.00768.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  31 in total

1.  Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation.

Authors:  Petros Zezos; Georgia Papaioannou; Nikolaos Nikolaidis; Themistoclis Vasiliadis; Olga Giouleme; Nikolaos Evgenidis
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Associations between microalbuminuria and animal foods, plant foods, and dietary patterns in the Multiethnic Study of Atherosclerosis.

Authors:  Jennifer A Nettleton; Lyn M Steffen; Walter Palmas; Gregory L Burke; David R Jacobs
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

3.  Blood concentration of aminothiols in children with relapse of nephrotic syndrome.

Authors:  Marcin Tkaczyk; Monika Miklaszewska; Jolanta Lukamowicz; Wojciech Fendler
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

4.  Clinical commentary: how to choose blood pressure goals and treatment: influence of estimated glomerular filtration rate and albuminuria.

Authors:  Matthew R Weir
Journal:  Trans Am Clin Climatol Assoc       Date:  2008

5.  Evaluation of heart rate recovery in patients with primary nephrotic syndrome.

Authors:  N Ozkayar; S Akyel; F Dede; F Akyel; D Turgut; M Bulut; A R Odabaş
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

6.  Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.

Authors:  Dimitrios Daoussis; Vasileios F Panoulas; Holly John; Tracey E Toms; Ioannis Antonopoulos; Gareth Treharne; Peter Nightingale; Karen M J Douglas; George D Kitas
Journal:  Clin Rheumatol       Date:  2010-04-16       Impact factor: 2.980

7.  Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.

Authors:  Mahmut Ilker Yilmaz; Alper Sonmez; Kayser Caglar; Deniz Engin Gok; Tayfun Eyileten; Müjdat Yenicesu; Cengizhan Acikel; Necati Bingol; Selim Kilic; Yusuf Oguz; Abdulgaffar Vural
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

8.  Associations of renal vascular resistance with albuminuria and other macroangiopathy in type 2 diabetic patients.

Authors:  Kumiko Hamano; Ai Nitta; Takayasu Ohtake; Shuzo Kobayashi
Journal:  Diabetes Care       Date:  2008-06-19       Impact factor: 19.112

Review 9.  Cardiovascular implications of proteinuria: an indicator of chronic kidney disease.

Authors:  Varun Agrawal; Victor Marinescu; Mohit Agarwal; Peter A McCullough
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

10.  Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004).

Authors:  Abhijit V Kshirsagar; Andrew S Bomback; Heejung Bang; Linda M Gerber; Suma Vupputuri; David A Shoham; Madhu Mazumdar; Christie M Ballantyne; James J Paparello; Philip J Klemmer
Journal:  Am J Cardiol       Date:  2007-12-21       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.